A former hedge fund manager has been found guilty of involvement in what US prosecutors say was the largest-ever insider trading scheme. Mathew Martoma used secrets from the clinical trials of a new drug for Alzheimer's to earn $275m. His lawyer says an appeal is planned against the possible 20 year prison sentence. Al Jazeera's Kristen Saloomey reports from New York.